- Home
- »
- Medical Devices
- »
-
Extracorporeal Membrane Oxygenation Machine Market Report 2030GVR Report cover
![Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Report]()
Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Analysis Report By Component (Pumps, Oxygenator, Controllers), By Modality (VA, VV, AV), By Patient Type, By Application, By Region, And Segment Forecasts, 2024 - 2030
- Report ID: GVR-1-68038-001-9
- Number of Report Pages: 130
- Format: PDF, Horizon Databook
- Historical Range: 2018 - 2023
- Forecast Period: 2024 - 2030
- Industry: Healthcare
Market Size & Trends
The global extracorporeal membrane oxygenation machine market size was valued at USD 307.9 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2030. This growth is driven by an increase in the incidence of cardiopulmonary diseases and respiratory failures. For instance, according to the Centers for Disease Control and Prevention (CDC), a person dies every 37 seconds due to cardiovascular disease in the U.S., underscoring the need for advanced medical technologies like extracorporeal membrane oxygenation (ECMO) machines.
COPD, a leading cause of death in the U.S in 2020, has significantly influenced the growth of the market. As per the American Lung Association report for 2022, 4.6% of adults, or 11.7 million people, reported a diagnosis of COPD, underscoring the rising prevalence of this condition. This rise in COPD cases has necessitated advanced life support technologies, sparking remarkable technological innovations within ECMO systems. Recently, advancements in this field have included the integration of hollow pumps, state-of-the-art oxygenators, and heparin-coated cannula. These improvements have enhanced the efficiency and applicability of ECMO systems across a range of surgical procedures.
The growing adoption of Extracorporeal Membrane Oxygenation (ECMO) machines in hospitals and the proliferation of awareness programs have been instrumental in driving the growth of the ECMO machine market. In the] U.S. alone, more than one hundred new ECMO programs have been established in the past 3-5 years, increasing the total number of ECMO programs to about 300 to 400. This growth is evident in the increasing number of procedures performed worldwide, reflecting the growing acceptance of these machines in healthcare settings. In recent times, Inspira Technologies OXY B.H.N. Ltd. introduced the "Liby" System in July 2022] , an advanced life support system designed to treat patients with life-threatening heart and lung failure. This development marks a significant milestone in the evolution of ECMO technology, further propelling the market forward.
The rapid adoption of ECMO machines in hospitals and the spread of awareness programs have been key catalysts for the growth of the market. Technological advancements in these systems, such as the incorporation of oxygenators, hollow pumps, and heparin-coated cannula, have allowed for various applications in surgeries. Furthermore, the development of smaller, more portable ECMO machines has expanded their usability and applications. The creation of portable adapters and compact ECMO machine circuits has facilitated the transportation of critically ill patients, further driving the market growth.
Moreover, the increasing geriatric population coupled with the rising incidence of coronary heart disease is bolstering the adoption of ECMO machines. As per the Population Reference Bureau's 2022 facts sheet, a 47% increase in the number of Americans 65 and older is expected by 2050, from fifty-eight million in 2022 to 82 million. This demographic shift, along with the strong association of coronary heart disease with age, is one of the leading causes of death worldwide, is driving the need for advanced life support technologies like ECMO machines. However, potential challenges such as infections, technical failures, bleeding, and the prohibitive cost of treatment may pose barriers to the market's growth.
Market Concentration & Characteristics
The market growth stage is high, and the pace of growth is accelerating due to the increasing prevalence of cardiopulmonary and respiratory diseases, necessitating the use of advanced life support technologies like ECMO machines. ECMO machine manufacturers, are continually investing in research and development to improve their technologies, which has led to a broader application of these systems in various surgeries. Technological advancements in these systems, such as the introduction of oxygenators, hollow pumps, and heparin-coated cannula, have expanded their applications and have resulted in a significant increase in the market size
Key strategies implemented by players in ECMO machine market are new product launches, expansion, acquisitions, partnerships, and other strategies. Companies are seeking to consolidate their position in the market, access modern technologies, and expand their customer base. For instance, in May 2020 Abiomed, known for producing the Impella heart pump, announced the acquisition of Breethe, a developer of a unique extracorporeal membrane oxygenation (ECMO) system. This acquisition is expected to enhance Abiomed's capability to provide comprehensive care for patients with severe respiratory conditions.
Degree of Innovation
The market has seen a high degree of innovation, with leading manufacturers constantly developing advanced products to aid in the treatment of heart or lung failures. For instance, in 2020, INTEGRIS Health and EMSA created a groundbreaking ECMO ambulance designed to offer specialized care in critical medical situations. This innovative vehicle marks a notable advancement in emergency medical services, guaranteeing prompt and advanced care for patients requiring immediate attention.
Impact of Regulations
Food and Drug Administration (FDA) in the U.S. and Health Canada in Canada. In Europe, the European Medicines Agency (EMA) oversees the regulatory landscape. Meanwhile, in the Asia Pacific region, the National Medical Products Administration (NMPA) in China plays a significant role in regulating ECMO machines. These regulatory bodies ensure the safety and efficacy of ECMO machines before they are approved for use in clinical settings.
Level of M&A Activities
Mergers and acquisitions in the ECMO machine market are on the rise and are expected to continue growing during the analysis period. Many companies are acquiring development-stage firms to expand their product portfolios and cater to a larger patient base. For instance, in October 2021 MicroPort Surgical, a critical care subsidiary of MicroPort Scientific, enhances emergency and critical care capabilities by acquiring Hemovent, a German ECLS technology specialist, for strategic ECMO market expansion, by integrating CPB with Hemovent's ECMO product development. These firms are also integrating advanced facilities and forming strategic alliances to leverage synergies in capabilities and resources, thereby enhancing their competitiveness in the market.
Service Substitute
The main substitutes for ECMO machines in the market are traditional ventilators and other mechanical ventilation methods. However, these alternatives often fall short in providing the necessary level of oxygenation and are typically reserved for less severe conditions.
Consolidate market
Major players like Medtronic, Getinge, and Maquet dominate the market with established brands, extensive distribution networks, and significant market share.
Regional Expansion
The market is experiencing robust global expansion. North America holds the largest market share, followed by Europe and China. The increasing prevalence of chronic diseases and a surge in heart and lung transplants are key factors driving this expansion. Additionally, advancements in lung pulmonary airway disease treatment, favorable reimbursement policies, and the expansion of the healthcare industry across developing regions of Asia and Africa are further contributing to the market's growth.Moreover, ECMO machine manufacturers in India are capitalizing on these opportunities to strengthen their market presence and contribute to the global market.
Component Insights
The oxygenators segment accounted for the largest market share of 34.61% in 2023 and shows the fastest CAGR over the forecast period. This can be attributed to their escalating prevalence of chronic diseases such as Chronic Obstructive Pulmonary Disease (COPD) and the increasing demand for heart and lung transplantation procedures. According to the World Health Organization (WHO ), COPD was the third leading cause of death globally, and resulting in approximately 3.23 million deaths. This alarming rise in the mortality rate due to respiratory and cardiovascular diseases is fueling the growth of the extracorporeal membrane oxygenation machine market.
The pumps segment has a considerable market share owing to excessive cost and usage. The pumps of ECMO machines are essential for moving blood from a patient to artificial lungs, which oxygenate the blood and return it to the patient. The growth of this segment is primarily attributed to its high usage in ECMO procedures and the availability of several types of pumps, including roller, impeller, and centrifugal pumps. These pumps are used in various applications of ECMO procedures based on their requirements. For instance , in 2020, INTEGRIS Health and EMSA unveiled a unique specialty care ECMO ambulance, demonstrating the practical application of these pumps.
Modality Insights
The veno-arterial segment accounted for the largest revenue share of 42.2% in 2023 and is expected to grow at a healthy CAGR during the forecast period. This growth can be attributed to its high usage in treating patients with cardiac arrest, where it assists with algorithm life support strategies to restore blood circulation. Additionally, the increasing incidence of chronic obstructive pulmonary disease (COPD) is also a key driver of this market segment. For instance, a research paper published by BMC Pulmonary Medicine in July 2022] stated that approximately 300 million people have COPD globally, with a prevalence of approximately 12.2%, indicating a significant need for advanced life support technologies like ECMO machines.
The veno-venous segment in the market captured a significant share in 2023 and is expected to witness lucrative growth during the forecast period.This segment's primary function is to simplify the exchange of oxygen and carbon dioxide, making it a prominent application in cases requiring lung support. The increasing incidence of chronic obstructive pulmonary disease (COPD) is a significant driver of this market segment. For instance, a study published by BMC Pulmonary Medicine in July 2022 revealed that approximately three hundred million people have COPD globally. Furthermore, recent industry developments, such as LivaNova PLC receiving FDA clearance for ECMO for LifeSPARC in November 2022, illustrate the continued innovation and growth in this sector.
Application Insights
The respiratory segment accounted for the largest revenue share of 44.10% in 2023 and is expected to grow at a fastest CAGR during the forecast period. This can be attributed to the high prevalence of respiratory disorders among patients, making ECMO machines a crucial tool for providing prolonged respiratory support. The increasing incidence of chronic diseases such as Chronic Obstructive Pulmonary Disease (COPD) is also a key driver of this market segment. The World Health Organization (WHO) estimates that 3.23 million people died from COPD in 2019, making it the third most common cause of death globally. This rise in the mortality rate of respiratory diseases is providing a significant impetus to the market growth.
The cardiac surgery segment in the ECMO market accounted for a considerable market share in 2023, owing to the increasing incidence of cardiac surgery and growing awareness about the use of ECMO machines in cardiac surgery. According to the American Heart Association 2022, the average age at the first heart attack was 65.6 years for males and 72.0 years for females. Every 40 seconds, someone in the U.S. experiences a myocardial infarction. Moreover, the rising cost of ECMO procedures, especially in cardiac surgery, is expected to drive the market growth.
Patient Type Insights
The adult patient segment accounted for the largest market revenue share of59.38% in 2023 and is also expected to grow at a fastest rate during the forecast period. This dominance can be attributed to the increasing prevalence of diseases such as coronary heart disease and the growing geriatric population. Cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for up to 17.9 million deaths each year. India bears over 60% of the global burden of heart disease, per a study conducted by the Registrar General of India and the Indian Council of Medical Research. This demographic shift is driving the need for advanced life support technologies like ECMO machines. Moreover, the increasing global burden of cardiac and respiratory diseases in adults due to consumption of alcohol, tobacco, and smoking coupled with a sedentary lifestyle drives the market.
The pediatric segment also accounted for the considerable market share and is expected to grow at a robust pace during the forecast period due to the increasing incidence of pediatric diseases that require advanced life support technologies, such as ECMO machines. The Registrar General of India and the Indian Council of Medical Research issued research indicating that the country's pediatric population is quickly expanding, necessitating the use of such innovative medical technologies.
Regional Insights
North America dominated the overall market in 2023 with a revenue share of 39.5%. This can be attributed due to government support for quality healthcare, high purchasing power parity, and the increasing prevalence of diseases such as chronic obstructive pulmonary disease in the U.S. and Canada. The presence of sophisticated healthcare facilities and favorable reimbursement policies has led to increased hospital admission rates which in turn is expected to boost the usage rates in this region.
The U.S. accounted for North America's largest share of the market in 2023. Country's well-developed healthcare infrastructure and a large patient population requiring ECMO machines, given the prevalence of chronic diseases and a high incidence of cardiac and respiratory failures. Additionally, the U.S. has consistently been a global leader in medical device innovation, attracting top manufacturers of ECMO machines. For instance, Medtronic, a leading global provider of medical technology solutions, has made significant strides in the ECMO machine market. Furthermore, the active involvement of the U.S. in the development and approval of ECMO machines has resulted in increased adoption and growth of this market segment.
The Asia Pacific region is expected to grow fastest during the forecast period. This progress is driven by are increase in healthcare expenditure by the government and private agencies to improve healthcare facilities. Economic development in countries such as Japan, India, and China coupled with rising government initiatives related to the development of healthcare infrastructure and reimbursement policies are further expected to augment the market growth.
The Japan accounted for Asia Pacific largest share of ECMO machine market in 2023. Japan has a highly developed healthcare infrastructure, which allows for early detection and treatment of diseases, increasing the demand for ECMO machines. In addition, the rising geriatric population and increasing healthcare spending in Japan have led to a surge in chronic disease cases, creating a demand for advanced life support technologies like ECMO machines.
Key Extracorporeal Membrane Oxygenation Machine Company Insights
The competitive scenario in the ECMO machine market is driven by both established players and new entrants, with innovation, market expansion, and niche specialization being key strategies. Emerging trends like portable systems, telemedicine, and AI are further shaping the landscape. Leading players invest heavily in R&D for portable, miniaturized, and AI-powered ECMO systems to cater to diverse patient needs and improve clinical outcomes. Established companies are looking to penetrate into new markets, particularly in developing regions with rising demand for ECMO therapy.
Key Extracorporeal Membrane Oxygenation Machine Companies:
The following are the leading companies in the extracorporeal membrane oxygenation machine market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these extracorporeal membrane oxygenation machine companies are analyzed to map the supply network.
- Medtronic Plc
- Maquet Holding
- Microport Scientific Corporation
- Terumo Cardiovascular System Corporation
- Medos Medizintechnik
- Nipro Medical Corporation
- LivaNova PLC
- CytoSorbents Corporation
- EUROSETS S.R.L
Recent Developments
-
In July 2023, BreathMo, a state-of-the-art ECMO system, was introduced at the ASAIO Conference, representing China's homegrown innovation in medical technology. This cutting-edge maglev technology addresses the unique medical needs of patients in China, marking a notable advancement in the field.
-
In April 2023, Abbott secured two new clearances from the U.S. Food and Drug Administration (FDA) for its acclaimed life support system, particularly the CentriMag Blood Pump. The extended FDA indication allows for longer-term use in adults depending on extracorporeal membrane oxygenation (ECMO), a vital life support method for those with heart and lung issues.
-
In November 2022, LivaNova PLC, the company announced the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation advanced circulatory support system, LifeSPARC. This approval signifies that the LifeSPARC system meets the criteria set forth by the FDA, and it can now be used in the U.S. market.
-
In July 2022 , Inspira Technologies OXY B.H.N Ltd., a pioneer in life support technology, introduced the "Liby" System. This advanced life support system is designed to treat patients with life-threatening heart and lung failure.
-
In July 2021, Xenios AG, a subsidiary of Fresenius Medical Care, received approval from the National Medical Products Administration (NMPA) in China for the use of its Xenios Console and patient kits in ECMO therapy. This approval comes following the successful registration of two patient kits in China.
Extracorporeal Membrane Oxygenation Machine Market Report Scope
Report Attribute
Details
Market size value in 2024
USD 322.9 million
Revenue forecast in 2030
USD 445.7 million
Growth Rate
CAGR of 5.5% from 2024 to 2030
Actual data
2018 - 2023
Forecast period
2024 - 2030
Report updated
February 2024
Quantitative units
Revenue in USD million/billion and CAGR from 2024 to 2030
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Component, Modality, Application, Patient Type
Regional scope
North America; Europe; Asia Pacific; Latin America; and MEA
Country scope
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.
Key companies profiled
Medtronic Plc; Maquet Holding; Microport Scientific Corporation; Terumo Cardiovascular System Corporation; Medos Medizintechnik; Nipro Medical Corporation; LivaNova PLC; CytoSorbents Corporation; and EUROSETS S.R.L
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Extracorporeal Membrane Oxygenation Machine Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global extracorporeal membrane oxygenation machine market report based on component, modality, patient type, application, and region
-
Extracorporeal Membrane Oxygenation (ECMO) Machine Component Outlook (Revenue, USD Million, 2018 - 2030)
-
Pumps
-
Oxygenator
-
Controllers
-
Cannula
-
Accessories
-
-
Extracorporeal Membrane Oxygenation (ECMO) Machine Modality Outlook (Revenue, USD Million, 2018 - 2030)
-
Veno-Arterial
-
Veno-Venous
-
Arterio-Venous
-
-
Extracorporeal Membrane Oxygenation (ECMO) Machine Patient Type Outlook (Revenue, USD Million, 2018 - 2030)
-
Neonates
-
Pediatric
-
Adult
-
-
Extracorporeal Membrane Oxygenation (ECMO) Machine Application Outlook (Revenue, USD Million, 2018 - 2030)
-
Respiratory
-
Neonates
-
Pediatric
-
Adult
-
-
Cardiac
-
Neonates
-
Pediatric
-
Adult
-
-
ECPR
-
Neonates
-
Pediatric
-
Adult
-
-
-
Extracorporeal Membrane Oxygenation (ECMO) Machine Region Outlook (Revenue, USD Million, 2018 - 2030)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia
-
South Korea
-
Thailand
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Frequently Asked Questions About This Report
b. The global extracorporeal membrane oxygenation machine market size was estimated at USD 307.9 million in 2023 and is expected to reach USD 322.9 million in 2024.
b. The global extracorporeal membrane oxygenation machine market is expected to grow at a compound annual growth rate of 5.5% from 2024 to 2030 to reach USD 445.7 million by 2030.
b. North America dominated the ECMO machine market with a share of 39.5% in 2023. This is attributable to government support for quality healthcare, high purchasing power parity of patients, and increasing prevalence of diseases such as chronic obstructive pulmonary disease (COPD).
b. Some key players operating in the ECMO machine market include Medtronic plc, Sorin Group, Terumo Cardiovascular Systems Corporation, MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Nipro Medical Corporation, and Microport Scientific Corporation.
b. Key factors that are driving the extracorporeal membrane oxygenation machine market growth include the rising prevalence of cardiopulmonary and respiratory diseases, increasing adoption of ECMO machines in hospitals, technological advancement in ECMO machines, and growing awareness towards the application of ECMO.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. ECMO Machine Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising prevalence of cardiopulmonary and respiratory diseases
3.2.1.2. Increasing adoption of ECMO machines in hospitals
3.2.1.3. Technological advancement in ECMO machines
3.2.1.4. Growing awareness towards the application of ECMO
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of procedures
3.2.2.2. Risk of complications during ECMO procedures
3.2.2.3. Presence of conventional technique
3.3. ECMO Machine Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. ECMO Machine Market: Component Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. ECMO Machine Market: Component Movement Analysis & Market Share, 2023 & 2030
4.3. Pumps
4.3.1. Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Oxygenator
4.4.1. Oxygenator Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Controllers
4.5.1. Controllers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Cannula
4.6.1. Cannula Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Accessories
4.7.1. Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. ECMO Machine Market: Modality Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. ECMO Machine Market: Modality Movement Analysis & Market Share, 2023 & 2030
5.3. Veno-Arterial
5.3.1. Veno-Arterial Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Veno-Venous
5.4.1. Veno-Venous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Arterio-Venous
5.5.1. Arterio-Venous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. ECMO Machine Market: Patient Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. ECMO Machine Market: Patient Type Movement Analysis & Market Share, 2023 & 2030
6.3. Neonates
6.3.1. Neonates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Pediatric
6.4.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Adult
6.5.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. ECMO Machine Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. ECMO machine Market: Application Movement Analysis & Market Share, 2023 & 2030
7.3. Respiratory
7.3.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. Respiratory Market Estimates and Forecast, By Patient Type 2018 - 2030 (USD Million)
7.3.2.1. Neonates
7.3.2.2. Pediatric
7.3.2.3. Adult
7.4. Cardiac
7.4.1. Cardiac Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. Cardiac Market Estimates and Forecast, By Patient Type 2018 - 2030 (USD Million)
7.4.2.1. Neonates
7.4.2.2. Pediatric
7.4.2.3. Adult
7.5. ECPR
7.5.1. ECPR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. ECPR Market Estimates and Forecast, By Patient Type 2018 - 2030 (USD Million)
7.5.2.1. Neonates
7.5.2.2. Pediatric
7.5.2.3. Adult
Chapter 8. ECMO Machine Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. ECMO Machine Market: Regional Movement Analysis & Market Share, 2023 & 2030
8.3. North America
8.3.1. North ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. U.S.
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. Reimbursement scenario
8.3.2.5. U.S. ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Reimbursement scenario
8.3.3.5. Canada ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. Europe
8.3.5. Europe ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. UK
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Reimbursement scenario
8.3.6.5. UK ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Germany
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Reimbursement scenario
8.3.7.5. Germany ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. France
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Reimbursement scenario
8.3.8.5. France ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Italy
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Reimbursement scenario
8.3.9.5. Italy ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.10. Spain
8.3.10.1. Key Country Dynamics
8.3.10.2. Competitive Scenario
8.3.10.3. Regulatory Framework
8.3.10.4. Reimbursement scenario
8.3.10.5. Spain ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.11. Denmark
8.3.11.1. Key Country Dynamics
8.3.11.2. Competitive Scenario
8.3.11.3. Regulatory Framework
8.3.11.4. Reimbursement scenario
8.3.11.5. Denmark ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.12. Sweden
8.3.12.1. Key Country Dynamics
8.3.12.2. Competitive Scenario
8.3.12.3. Regulatory Framework
8.3.12.4. Reimbursement scenario
8.3.12.5. Sweden ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.13. Norway
8.3.13.1. Key Country Dynamics
8.3.13.2. Competitive Scenario
8.3.13.3. Regulatory Framework
8.3.13.4. Reimbursement scenario
8.3.13.5. Norway ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Reimbursement scenario
8.4.2.5. Japan ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Reimbursement scenario
8.4.3.5. China ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Reimbursement scenario
8.4.4.5. India ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Reimbursement scenario
8.4.5.5. South Korea ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Reimbursement scenario
8.4.6.5. Australia ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Reimbursement scenario
8.4.7.5. Thailand ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement scenario
8.5.2.5. Brazil ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement scenario
8.5.3.5. Mexico ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Reimbursement scenario
8.5.4.5. Argentina ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East & Africa
8.6.1. Middle East & Africa ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement scenario
8.6.2.5. South Africa ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Reimbursement scenario
8.6.3.5. Saudi Arabia ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Reimbursement scenario
8.6.4.5. UAE ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Reimbursement scenario
8.6.5.5. Kuwait ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Key Company Profiles
9.2.1. Medtronic Plc
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Maquet Holding
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Microport Scientific Corporation
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Terumo Cardiovascular System Corporation
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Medos Medizintechnik
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Nipro Medical Corporation
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. LivaNova PLC
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. CytoSorbents Corporation
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. EUROSETS S.R.L
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 4. Global ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 5. Global ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 6. Global ECMO machine market, application, 2018 - 2030 (USD Million)
Table 7. Global ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 8. North America ECMO machine market, by region, 2018 - 2030 (USD Million)
Table 9. North America ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 10. North America ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 11. North America ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 12. North America ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 13. North America Respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 14. North America Cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 15. North America ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 16. U.S ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 17. U.S. ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 18. U.S. ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 19. U.S. ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 20. U.S. Respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 21. U.S. Cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 22. U.S. ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 23. Canada ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 24. Canada ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 25. Canada ECMO machine market, by patient type component, 2018 - 2030 (USD Million)
Table 26. Canada ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 27. Canada Respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 28. Canada Cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 29. Canada ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 30. Europe ECMO machine market, by region, 2018 - 2030 (USD Million)
Table 31. Europe ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 32. Europe ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 33. Europe ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 34. Europe ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 35. Europe Respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 36. Europe Cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 37. Europe ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 38. U.K. ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 39. U.K. ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 40. U.K. ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 41. U.K. ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 42. U.K. respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 43. U.K. cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 44. U.K. ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 45. Germany ECMO machine market, by component Type, 2018 - 2030 (USD Million)
Table 46. Germany ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 47. Germany ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 48. Germany ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 49. Germany respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 50. Germany cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 51. Germany ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 52. Italy ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 53. Italy ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 54. Italy ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 55. Italy ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 56. Italy respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 57. Italy cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 58. Italy ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 59. France ECMO machine market, by component Type, 2018 - 2030 (USD Million)
Table 60. France ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 61. France ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 62. France ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 63. France respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 64. France cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 65. France ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 66. Spain ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 67. Spain ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 68. Spain ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 69. Spain ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 70. Spain respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 71. Spain cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 72. Spain ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 73. Denmark ECMO machine market, by component Type, 2018 - 2030 (USD Million)
Table 74. Denmark ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 75. Denmark ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 76. Denmark ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 77. Denmark respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 78. Denmark cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 79. Denmark ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 80. Sweden ECMO machine market, by component Type, 2018 - 2030 (USD Million)
Table 81. Sweden ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 82. Sweden ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 83. Sweden ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 84. Sweden respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 85. Sweden cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 86. Sweden ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 87. Norway ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 88. Norway ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 89. Norway ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 90. Norway ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 91. Norway respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 92. Norway cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 93. Norway ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 94. Asia Pacific ECMO machine market, by region, 2018 - 2030 (USD Million)
Table 95. Asia Pacific ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 96. Asia Pacific ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 97. Asia Pacific ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 98. Asia Pacific ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 99. Asia Pacific respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 100. Asia Pacific cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 101. Asia Pacific ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 102. Japan ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 103. Japan ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 104. Japan ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 105. Japan ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 106. Japan respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 107. Japan cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 108. Japan ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 109. China ECMO machine market, by component Type, 2018 - 2030 (USD Million)
Table 110. China ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 111. China ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 112. China ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 113. China respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 114. China cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 115. China ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 116. India ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 117. India ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 118. India ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 119. India ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 120. India respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 121. India cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 122. India ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 123. Australia ECMO machine market, by component Type, 2018 - 2030 (USD Million)
Table 124. Australia ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 125. Australia ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 126. Australia ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 127. Australia respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 128. Australia cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 129. Australia ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 130. South Korea ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 131. South Korea ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 132. South Korea ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 133. South Korea ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 134. South Korea respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 135. South Korea cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 136. South Korea ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 137. Thailand ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 138. Thailand ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 139. Thailand ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 140. Thailand ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 141. Thailand respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 142. Thailand cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 143. Thailand ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 144. Philippines ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 145. Latin AMERICA ECMO machine market, by region, 2018 - 2030 (USD Million)
Table 146. Latin America ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 147. Latin America ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 148. Latin America ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 149. Latin America ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 150. Latin America respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 151. Latin America cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 152. Latin America ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 153. Brazil ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 154. Brazil ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 155. Brazil ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 156. Brazil ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 157. Brazil respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 158. Brazil cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 159. Brazil ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 160. Mexico ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 161. Mexico ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 162. Mexico ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 163. Mexico ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 164. Mexico respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 165. Mexico cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 166. Mexico ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 167. Argentina ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 168. Argentina ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 169. Argentina ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 170. Argentina ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 171. Argentina respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 172. Argentina cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 173. Argentina ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 174. Middle East & Africa ECMO machine market, by region, 2018 - 2030 (USD Million)
Table 175. Middle East & Africa ECMO machine market, by component, 2018 - 2030 (USD Million)
Table 176. Middle East & Africa ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 177. Middle East & Africa ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 178. Middle East & Africa ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 179. Middle East & Africa respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 180. Middle East & Africa cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 181. Middle East & Africa South Africa ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 182. South Africa ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 183. South Africa ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 184. South Africa ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 185. South Africa respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 186. South Africa cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 187. South Africa ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 188. Saudi Arabia ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 189. Saudi Arabia ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 190. Saudi Arabia ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 191. Saudi Arabia ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 192. Saudi Arabia respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 193. Saudi Arabia cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 194. Saudi Arabia ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 195. UAE ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 196. UAE ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 197. UAE ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 198. UAE ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 199. UAE respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 200. UAE cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 201. UAE ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 202. Kuwait ECMO machine market, by component type, 2018 - 2030 (USD Million)
Table 203. Kuwait ECMO machine market, by modality, 2018 - 2030 (USD Million)
Table 204. Kuwait ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 205. Kuwait ECMO machine market, by application, 2018 - 2030 (USD Million)
Table 206. Kuwait respiratory ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 207. Kuwait cardiac ECMO machine market, by patient type, 2018 - 2030 (USD Million)
Table 208. Kuwait ECPR ECMO machine market, by patient type, 2018 - 2030 (USD Million)
List of Figures
Fig 1. Information Procurement
Fig 2. Primary Research Pattern
Fig 3. Market Research Approaches
Fig 4. Value Chain-Based Sizing & Forecasting
Fig 5. Market Formulation & Validation
Fig 6. ECMO machine market segmentation
Fig 7. Market driver analysis (Current & future impact)
Fig 8. Market restraint analysis (Current & future impact)
Fig 9. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig 10. Porter’s Five Forces Analysis
Fig 11. ECMO machine market, component outlook key takeaways (USD Million)
Fig 12. ECMO machine market: component movement analysis (USD Million), 2023 & 2030
Fig 13. Blood pumps market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 14. Oxygenators market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 15. Heater market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 16. Tubing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 17. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 18. ECMO machine market: modality movement analysis (USD Million), 2023 & 2030
Fig 19. Veno-Arterial market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 20. Veno-Venous market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 21. Arterio-Venous market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 22. ECMO machine market: application movement analysis (USD Million), 2023 & 2030
Fig 23. Respiratory market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 24. Cardiac market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 25. ECPR market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 26. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 27. ECMO machine market: patient type movement analysis (USD Million), 2023 & 2030
Fig 28. Respiratory ECMO machine market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 29. Cardiac ECMO machine market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 30. ECPR ECMO machine market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 31. Regional outlook, 2023 & 2030, USD Million
Fig 32. North America ECMO machine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 33. U.S. ECMO machine market, 2018 - 2030 (USD Million)
Fig 34. Canada ECMO machine market, 2018 - 2030 (USD Million)
Fig 35. Europe ECMO machine market, 2018 - 2030 (USD Million)
Fig 36. UK ECMO machine market, 2018 - 2030 (USD Million)
Fig 37. Germany ECMO machine market, 2018 - 2030 (USD Million)
Fig 38. France ECMO machine market, 2018 - 2030 (USD Million)
Fig 39. Spain ECMO machine market, 2018 - 2030 (USD Million)
Fig 40. Italy ECMO machine market, 2018 - 2030 (USD Million)
Fig 41. Sweden ECMO machine market, 2018 - 2030 (USD Million)
Fig 42. Norway ECMO machine market, 2018 - 2030 (USD Million)
Fig 43. Denmark ECMO machine market, 2018 - 2030 (USD Million)
Fig 44. Asia Pacific ECMO machine market, 2018 - 2030 (USD Million)
Fig 45. China ECMO machine market, 2018 - 2030 (USD Million)
Fig 46. Japan ECMO machine market, 2018 - 2030 (USD Million)
Fig 47. India ECMO machine market, 2018 - 2030 (USD Million)
Fig 48. South Korea ECMO machine market, 2018 - 2030 (USD Million)
Fig 49. Australia ECMO machine market, 2018 - 2030 (USD Million)
Fig 50. Thailand ECMO machine market, 2018 - 2030 (USD Million)
Fig 51. Latin America ECMO machine market, 2018 - 2030 (USD Million)
Fig 52. Brazil ECMO machine market, 2018 - 2030 (USD Million)
Fig 53. Mexico ECMO machine market, 2018 - 2030 (USD Million)
Fig 54. Argentina ECMO machine market, 2018 - 2030 (USD Million)
Fig 55. Middle East and Africa ECMO machine market, 2018 - 2030 (USD Million)
Fig 56. South Africa ECMO machine market, 2018 - 2030 (USD Million)
Fig 57. Saudi Arabia ECMO machine market, 2018 - 2030 (USD Million)
Fig 58. UAE ECMO machine market, 2018 - 2030 (USD Million)
Fig 59. Kuwait ECMO machine market, 2018 - 2030 (USD Million)Market Segmentation
- ECMO Machine Market, By Component Outlook (Revenue, USD Million, 2018 - 2030)
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- ECMO Machine Market, By Modality Outlook (Revenue, USD Million, 2018 - 2030)
- Veno-Arterial
- Veno-Venous
- Arterio-Venous
- ECMO Machine Market, By Patient Type (Revenue, USD Million, 2018 - 2030)
- Neonates
- Pediatric
- Adult
- ECMO Machine Market, By Application (Revenue, USD Million, 2018 - 2030)
- Respiratory
- Neonates
- Pediatric
- Adult
- Cardiac
- Neonates
- Pediatric
- Adult
- ECPR
- Neonates
- Pediatric
- Adult
- Respiratory
- ECMO Machine Market, Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- North America ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- North America ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- North America ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- U.S.
- U.S. ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- U.S. ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- U.S. ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- U.S. ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- U.S. ECMO machine market, by component
- Canada
- Canada ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Canada ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Canada ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Canada ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Canada ECMO machine market, by component
- North America ECMO machine market, by component
- Europe
- Europe ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Europe ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Europe ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Europe ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- UK
- UK ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- UK ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- UK ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- UK ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- UK ECMO machine market, by component
- Germany
- Germany ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Germany ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Germany ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Germany ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Germany ECMO machine market, by component
- France
- France ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- France ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- France ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- France ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- France ECMO machine market, by component
- Italy
- Italy ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Italy ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Italy ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Italy ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Italy ECMO machine market, by component
- Spain
- Spain ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Spain ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Spain ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Spain ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Spain ECMO machine market, by component
- Denmark
- Denmark ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Denmark ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Denmark ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Denmark ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Denmark ECMO machine market, by component
- Sweden
- Sweden ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Sweden ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Sweden ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Sweden ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Sweden ECMO machine market, by component
- Norway
- Norway ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Norway ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Norway ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Norway ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Norway ECMO machine market, by component
- Europe ECMO machine market, by component
- Asia Pacific
- Asia Pacific ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Asia Pacific ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Asia Pacific ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Asia Pacific ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Japan
- Japan ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Japan ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Japan ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Japan ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Japan ECMO machine market, by component
- China
- China ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- China ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- China ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- China ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- China ECMO machine market, by component
- India
- India ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- India ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- India ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- India ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- India ECMO machine market, by component
- Australia
- Australia ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Australia ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Australia ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Australia ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Australia ECMO machine market, by component
- South Korea
- South Korea ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- South Korea ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- South Korea ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- South Korea ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- South Korea ECMO machine market, by component
- Thailand
- Thailand ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Thailand ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Thailand ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Thailand ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Thailand ECMO machine market, by component
- Asia Pacific ECMO machine market, by component
- Latin America
- Latin America ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Latin America ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Latin America ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Latin America ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Brazil
- Brazil ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Brazil ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Brazil ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Brazil ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Brazil ECMO machine market, by component
- Mexico
- Mexico ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Mexico ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Mexico ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Mexico ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Mexico ECMO machine market, by component
- Argentina
- Argentina ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Argentina ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Argentina ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Argentina ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Argentina ECMO machine market, by component
- Latin America ECMO machine market, by component
- Middle East & Africa
- Middle East & Africa ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Middle East & Africa ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Middle East & Africa ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Middle East & Africa ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- South Africa
- South Africa ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- South Africa ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- South Africa ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- South Africa ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- South Africa ECMO machine market, by component
- Saudi Arabia
- Saudi Arabia ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Saudi Arabia ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Saudi Arabia ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Saudi Arabia ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Saudi Arabia ECMO machine market, by component
- UAE
- UAE ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- UAE ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- UAE ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- UAE ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- UAE ECMO machine market, by component
- Kuwait
- Kuwait ECMO machine market, by component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Kuwait ECMO machine market, by modality
- Veno-Arterial
- Veno-venous
- Arterio-Venous
- Kuwait ECMO machine market, by patient type
- Neonates
- Pediatric
- Adult
- Kuwait ECMO machine market, by application
- Respiratory
- Cardiac
- ECPR
- Kuwait ECMO machine market, by component
- Middle East & Africa ECMO machine market, by component
- North America
Extracorporeal Membrane Oxygenation Machine Market Dynamics
Drivers: Rising Prevalence of Cardiopulmonary and Respiratory Diseases
Respiratory diseases include conditions such as bronchiectasis, hypersensitivity pneumonitis, lung fibrosis, asthma, Chronic Obstructive Pulmonary Disease (COPD), and lung cancer. COPD is among the leading causes of death in the U.S. after cancer and cardiac diseases. Each year, over 11 million people in the U.S. get diagnosed with COPD according to a report from the America Lung Association. In the year 2012 in Europe, as many as 403,000 deaths resulted from respiratory diseases, which was equal to 8% of overall deaths in the same year, as per the statistics of Eurostat. In addition, according to the WHO, more than 3 million people suffered from asthma in 2015 in Japan, 7% of which were severe cases while 30% had moderate asthma. Furthermore, according to the WHO, 17.5 million people die because of cardiovascular diseases globally which is estimated to be equal to 31% of all deaths globally. Unhealthy diet, physical inactivity, intake of tobacco, and smoking are among the prime causes of cardiopulmonary diseases. Nearly 80% of deaths arising due to cardiovascular diseases are due to the occurrence of stroke or heart attack. Therefore, the constant rise in cardiovascular and respiratory diseases globally is expected to drive market growth.
Increasing Adoption Rate of ECMO Machines in Hospitals
ECMO devices are used for treating patients suffering from chronic respiratory and cardiopulmonary diseases and provide extracorporeal life support for severe cardiopulmonary conditions. It has a wide number of applications including the treatment of neonates, pediatric, and adult populations. ECMO also helps in ventilation, oxygenation, and cardiac output. The introduction of hollow pumps, oxygenators, and heparin-coated cannula used for various applications in surgeries are some of the advancements made in this field. For instance, Terumo Cardiovascular System’s CAPIOX RX oxygenator uses hollow fiber technology, which helps in complete process control ranging from raw material to finished product. The recently developed ECMOs are comparatively smaller, increasing their portability and applications. Furthermore, portable adaptors and compact ECMO circuits have also been developed to help during the transportation of critically ill patients. These advantages of the ECMO systems have significantly increased its adoption rate in hospitals.
Restraint: High Cost of Procedures
ECMO technology advancements have led to an increase in the cost of ECMO procedures. A single ECMO procedure costs about USD 73,122 in Europe, according to the European journal of cardio-thoracic surgery. This can act as a restraining factor for the market growth during the forecast period. In addition, according to the U.S. National Institute of Health, ECMO cost varies in and outside the U.S. So far, the highest amount paid in the U.S. was for Congenital Diaphragmatic Hernia (CDH) while outside the U.S., the highest cost of ECMO was observed in the case of cardiac illnesses rather than for respiratory and CDH repair conditions. The mean cost for a single ECMO procedure is USD 73,122. The total hospital cost including pre and post ECMO costs is USD 213,246. The cost of a single ECMO procedure is about USD 73,122 in Europe, according to the European journal of cardio-thoracic surgery. This may act as one of the restraining factors for the growth of the market during the forecast period.
What Does This Report Include?
This section will provide insights into the contents included in this extracorporeal membrane oxygenation machine market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Extracorporeal membrane oxygenation machine market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Extracorporeal membrane oxygenation machine market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
Research Methodology
A three-pronged approach was followed for deducing the extracorporeal membrane oxygenation machine market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for extracorporeal membrane oxygenation machine market to gather the most reliable and current information possible.
- We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
- We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
- We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
- We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
- We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of extracorporeal membrane oxygenation machine market data depending on the type of information we’re trying to uncover in our research.
-
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
-
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
-
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
-
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
-
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
-
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
-
This step also entails the finalization of the report scope and data representation pattern.
-
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
Extracorporeal Membrane Oxygenation Machine Market Categorization:
The extracorporeal membrane oxygenation machine market was categorized into five segments, namely component (Pumps, Oxygenator, Controllers, Cannula, Accessories), modality (Veno-Arterial, Veno-Venous, Arterio-Venous), patient type (Neonates, Pediatric, Adult), application (Respiratory, Cardiac, ECPR) and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).
Segment Market Methodology:
The extracorporeal membrane oxygenation machine market was segmented into component, modality, patient type, application, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Market research approaches: Bottom-up
-
Demand estimation of each product across countries/regions summed up to from the total market.
-
Variable analysis for demand forecast.
-
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
-
Primary interviews for data revalidation and insight collection.
Market research approaches: Top-down
-
Used extensively for new product forecasting or analyzing penetration levels.
-
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
-
Primary interviews and vendor-based primary research for variable impact analysis.
Market research approaches: Combined
- This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.
Regional Market Methodology:
The extracorporeal membrane oxygenation machine market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-four countries, namely, the U.S.; Canada; the UK.; Germany; France; Italy; Spain; Sweden; Denmark ; Norway ; Japan; China; India; South Korea; Thailand; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; UAE; Kuwait; and Saudi Arabia.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
Extracorporeal membrane oxygenation machine market companies & financials:
The extracorporeal membrane oxygenation machine market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
-
Maquet Holding, Maquet Holding, founded in the year 1838, is headquartered in Germany and operates as a subsidiary of Getinge AB. It is engaged in developing infrastructure and therapeutic solutions for hospitals and its product portfolio includes products for hybrid operating rooms, patient transport, catheter laboratories, hospital solutions, and critical care units. The infrastructure solutions include counterpulsation therapy devices, extracorporeal life support systems, modular room systems, anesthesia delivery systems, and other such solutions for operating rooms. In addition, the company designs and distributes solutions for critical care, anesthesia, gynecology, and biosurgery.
-
Medtronic, Medtronic applies biomedical engineering in research, design, and manufacturing and provides products for alleviating pain, restoring health, and extending life. The company serves patients, clinicians, physicians, and hospitals in over 140 countries worldwide. It offers therapeutic solutions for cardiovascular diseases, diabetes, cancer, and neurological and musculoskeletal conditions. The company operates through three segments, namely the restorative therapies group, the cardiac and vascular group, and the diabetes group. The company secures rights for more than 53,000 patents. In 2015, Medtronic acquired Covidien plc, a global healthcare products company. This acquisition has helped the company position itself as a leading company in the healthcare industry.
-
Microport Scientific Corporation, MicroPort Scientific Corporation was founded in 1998 and is headquartered in China. It functions as a subsidiary of Otsuka Medical Devices Co., Ltd. The company is involved in the manufacturing and marketing of medical devices for indications such as cardiovascular, orthopedics, electrophysiological, endovascular, neurovascular, endocrinal, diabetes management, and others. The cardiovascular segment of the company’s products includes dilation catheters, coronary stents, and delivery systems. The surgical segment of the company includes products and devices for extracorporeal circulation, which are commonly used in congenital heart disease cases.
-
Terumo Cardiovascular Systems Corporation, Terumo Cardiovascular Systems, founded in the year 1999 is headquartered in the U.S. and is a subsidiary of the Terumo Medical Corporation. It specializes in the development of products for vascular and cardiac surgery. The company operates in all 5 continents through a well-developed distribution channel. The product portfolio of the company comprises devices for autotransfusion, endoscopy, beating heart and surgical stabilization products, perfusion, sternotomy, monitoring systems, and cannulae. These are used in intra-operative monitoring, cardiopulmonary bypass, and vascular grafting.
-
Medos Medizintechnik, Headquartered in Germany, Medos Medizintechnik was founded in 1987. In 2013, the company underwent a merger with Novalung, forming its parent company Xenios. . Following the merger, the company catered to cardiovascular as well as pulmonary disorders owing to similar anatomical and technology platform requirements. Later in 2016, the company was acquired by a renal specialty hospital called Fresenius Medical Care. It is a private company that participates in the manufacturing and distribution of various medical devices, like products required for ECMOs, cardiac surgery, and ventricle assist devices (VADs). Their product portfolio comprises VAD-apex cannulae, arterial-VAD-cannulae, HILITE reservoirs, tubing sets, perfusion sets, pressure measuring sets, pre-bypass sets, hemofilters, and others. The customers of the company comprise perfusionists and cardiac surgeons mainly.
-
Nipro Medical Corporation, NIPRO Medical Corporation is a combination of businesses like medical devices, pharmaceutical packaging, and pharmaceuticals. The company manufactures products for interventional radiology, renal, cardiopulmonary, and medical surgery for human as well as veterinary needs. The company offers products such as blood-tubing sets, IV catheters, blood collection needles, hypodermic needles, ELISIO dialyzers, safety-winged infusion sets, and adapters.
-
LivaNova PLC, LivaNova PLC was formed as a result of the merging of Cyberonics which is a U.S.-based healthcare company along with Sorin Group which is an Italy-based medical devices company. It specializes in medical technologies, cardiac rhythm management, and products for cardiac surgery as well as cardiovascular diseases. LivaNova PLC develops products that treat cardiac rhythm disorders and devices used in cardiac surgery. The company has a distribution network spread across 100 countries.
-
CytoSorbents Corporation, CytoSorbents Corporation is a critical care immunotherapy company specializing in producing blood purification technology for humans as well as animals. The company develops products to control deadly inflammation in critically ill patients. Its product portfolio includes effective extracorporeal cytokine adsorber and purification technologies that assist in blood transfusions, preventing any fatal reactions. The company has a distribution network spread across 55 countries.
Value chain-based sizing & forecasting
Supply Side Estimates
-
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
-
Segment revenue determination via variable analysis and penetration modeling.
-
Competitive benchmarking to identify market leaders and their collective revenue shares.
-
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
-
Identifying parent markets and ancillary markets
-
Segment penetration analysis to obtain pertinent
-
revenue/volume
-
Heuristic forecasting with the help of subject matter experts
-
Forecasting via variable analysis
Extracorporeal Membrane Oxygenation Machine Market Report Objectives:
-
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
-
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
-
Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
Extracorporeal Membrane Oxygenation Machine Market Report Assumptions:
-
The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
-
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
-
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
-
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
-
Inflation has not been accounted for to estimate and forecast the market.
-
Numbers may not add up due to rounding off.
-
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
-
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
-
Latin America includes Central American countries and the South American continent
-
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
Primary Research
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
-
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
-
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
![pdf icn]()
GET A FREE SAMPLE
![arrow icn]()
This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.
![gvr icn]()
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
![Certified Icon]()
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
